JP2006055151A - Method for producing natto - Google Patents
Method for producing natto Download PDFInfo
- Publication number
- JP2006055151A JP2006055151A JP2004270549A JP2004270549A JP2006055151A JP 2006055151 A JP2006055151 A JP 2006055151A JP 2004270549 A JP2004270549 A JP 2004270549A JP 2004270549 A JP2004270549 A JP 2004270549A JP 2006055151 A JP2006055151 A JP 2006055151A
- Authority
- JP
- Japan
- Prior art keywords
- natto
- lysine
- threonine
- amino acids
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Beans For Foods Or Fodder (AREA)
Abstract
Description
本発明は、微生物の育種およびその利用に係り、更に詳細には、本発明は、必須アミノ酸、特にL−リジン、L−スレオニン、分岐鎖アミノ酸の生産性を向上させた納豆菌の育種、その育種納豆菌、その育種納豆菌を用いたこれらのアミノ酸を多く含む納豆の製造法、及びその育種納豆菌を使用して製造した納豆に関する。The present invention relates to the breeding of microorganisms and the use thereof, more specifically, the present invention relates to the breeding of Bacillus natto with improved productivity of essential amino acids, particularly L-lysine, L-threonine and branched chain amino acids, The present invention relates to breeding natto bacteria, a method for producing natto containing many of these amino acids using the breeding natto bacteria, and natto produced using the breeding natto bacteria.
L−リジン、L−スレオニン、分岐鎖アミノ酸(L−バリン、L−ロイシン、L−イソロイシン)は、いずれも必須アミノ酸として重要なアミノ酸であることが知られている。これらのアミノ酸の工業的製造法としては、ブレビバクテリウム ラクトファーメンタム、コリネバクテリウム グルタミクム、エシェリヒア コリーなどの変異株または組換え体を使用して糖を主原料とする直接発酵法が主流となっている。L-lysine, L-threonine, and branched chain amino acids (L-valine, L-leucine, L-isoleucine) are all known to be important amino acids as essential amino acids. As the industrial production method of these amino acids, the direct fermentation method using sugar as the main raw material using mutants or recombinants such as Brevibacterium lactofermentum, Corynebacterium glutamicum, Escherichia coli, etc. has become the mainstream. ing.
L−リジンは蛋白質中に存在し、又アサリ、カラス貝等の貝類、多くの発芽植物に遊離して存在している。生理上重要なアミノ酸で、代表的な必須アミノ酸である。人や家畜はL−リジンを体内で生合成することができないため、L−リジンを食物から摂取する必要がある。米や小麦粉は地球レベルでの主食であり、アミノ酸で構成される蛋白質の重要な供給源である。然し、米や小麦粉では、理想的な母乳のアミノ酸パターンと比較して、L−リジンが最も不足している。L-lysine is present in proteins, and is liberated in shellfish such as clams and crows and many germinating plants. It is a physiologically important amino acid and a typical essential amino acid. Since humans and livestock cannot biosynthesize L-lysine in the body, it is necessary to take L-lysine from food. Rice and flour are staple foods at the global level and are an important source of proteins composed of amino acids. However, rice and wheat flour are most deficient in L-lysine compared to the ideal breast milk amino acid pattern.
L−スレオニンは重要な蛋白質構成アミノ酸として知られている。代表的な必須アミノ酸であり、小麦粉ではL−リジンに次いで不足しているアミノ酸である。L-threonine is known as an important protein constituent amino acid. It is a typical essential amino acid, which is the amino acid that is deficient next to L-lysine in wheat flour.
分岐鎖アミノ酸として、L−ロイシン、L−バリン、L−イソロイシンが知られている。L−ロイシンは蛋白質中に存在し、肝臓、脾臓、発芽植物などに遊離の状態で存在している。又、L−バリンは亜麻仁蛋白質などの蛋白質中に存在し、発芽植物に遊離の状態で存在している。更に、L−イソロイシンは蛋白質中に存在し、エラスチンやカゼインなどの蛋白質中に存在し、甜菜糖蜜や発芽植物などに遊離の状態で存在している。これらの分岐鎖アミノ酸は、いずれも代表的な必須アミノ酸であり、小麦粉ではL−ロイシンはL−リジン、L−スレオニンに次いで不足しているアミノ酸であり、L−バリンとL−イソロイシンも不足しているアミノ酸である。これらの3つの分岐鎖アミノ酸は、生体の蛋白質を増加させる働きや、運動をしたときの筋肉のエネルギー源、運動時の持久力の向上、更には疲労感からの回復効果などさまざまの重要な役割をしている。L-leucine, L-valine, and L-isoleucine are known as branched chain amino acids. L-leucine is present in proteins and is present in a free state in the liver, spleen, germinating plants and the like. L-valine is present in proteins such as flaxseed protein and is present in a free state in germinating plants. Furthermore, L-isoleucine is present in proteins, is present in proteins such as elastin and casein, and is present in a free state in sugar beet molasses and germinating plants. All of these branched chain amino acids are typical essential amino acids. In wheat flour, L-leucine is the second missing amino acid after L-lysine and L-threonine, and L-valine and L-isoleucine are also deficient. Is an amino acid. These three branched-chain amino acids play various important roles such as increasing protein in the body, muscular energy source when exercising, improving endurance during exercise, and recovery from fatigue. I am doing.
大豆を納豆菌で発酵した大豆発酵食品である納豆は、伝統的な日本発の栄養食品であり、最近は欧米にも愛好者が増えてきた。Natto, a fermented soy bean fermented with natto bacteria, is a traditional nutritional food from Japan. Recently, the number of enthusiasts has also increased in Europe and America.
納豆菌で大豆を発酵させると、納豆菌の持つプロテアーゼにより大豆蛋白質が分解されてペプチドやアミノ酸が生成し、蛋白質の消化・吸収を向上させる。When fermenting soybeans with Bacillus natto, the soybean protein is decomposed by the protease of Bacillus natto to produce peptides and amino acids, thereby improving the digestion and absorption of the protein.
大豆を納豆菌で発酵させた納豆は、アミノ酸の供給源として極めて好ましい食品といえる。Natto fermented with natto bacteria can be said to be a highly preferred food as an amino acid source.
しかし、米や小麦粉などを主食とする場合、含有している蛋白質による生理的効果を十分に引き出すには、副食としての現状の納豆に由来の必須アミノ酸であるL−リジン、L−スレオニン、分岐鎖アミノ酸の含有量のままでは不十分と考えられることから、さらに高濃度にL−リジン、L−スレオニン、分岐鎖アミノ酸を含有する納豆を開発することが必要である。然し、納豆中のL−リジン、L−スレオニン、分岐鎖アミノ酸含有量を増大させようとする創意・工夫は見当たらない。However, when rice or wheat flour is used as a staple food, L-lysine, L-threonine, branching, which are essential amino acids derived from the current natto as a side meal, are sufficient to bring out the physiological effects of the contained protein. Since it is considered that the chain amino acid content is not sufficient, it is necessary to develop natto containing L-lysine, L-threonine, and branched chain amino acids at higher concentrations. However, there is no inventive idea to increase the contents of L-lysine, L-threonine and branched chain amino acids in natto.
納豆にL−リジン、L−スレオニン、分岐鎖アミノ酸を別途に添加することが考えられるが、安価な納豆のコスト増につながるので、好ましい方法ではない。従って、納豆菌の能力を人為的に向上させることにより、自然な形でL−リジン、L−スレオニン、分岐鎖アミノ酸の含有量を高めることが求められる。Although it is conceivable to separately add L-lysine, L-threonine, and branched chain amino acids to natto, this is not a preferable method because it leads to an increase in the cost of inexpensive natto. Therefore, it is required to increase the contents of L-lysine, L-threonine and branched chain amino acids in a natural manner by artificially improving the ability of Bacillus natto.
本発明は、米や小麦粉など穀物由来の蛋白質の栄養価を高め、生体の構成酵素の構成アミノ酸となり、且つ筋肉のエネルギー源としての生理作用が期待できるL−リジン、L−スレオニン、分岐鎖アミノ酸を市販の納豆よりも高濃度に含有する納豆を提供することを目的としている。The present invention increases L-lysine, L-threonine, and branched chain amino acids that increase the nutritional value of cereal-derived proteins such as rice and wheat flour, become constituent amino acids of living body constituent enzymes, and can be expected to have physiological effects as muscle energy sources The purpose is to provide natto containing natto at a higher concentration than commercial natto.
本発明者等は、納豆のL−リジン、L−スレオニン、分岐鎖アミノ酸などの遊離アミノ酸の含有量を向上させる手段を各種検討し、納豆菌自体のこれらのアミノ酸の生成能力を人為的に改良することが出来ると考えて本発明を推進した。The inventors have studied various means for improving the content of free amino acids such as L-lysine, L-threonine and branched chain amino acids in natto, and artificially improved the ability of natto itself to produce these amino acids. The present invention was promoted because it was possible to do so.
納豆菌は、稲ワラなどに付着して自然界には広く存在している。分類学的にはバチルス・サチルスに分類されているが、納豆特有の粘質物を生成し且つビオチンを要求することからバチルス・ナットウとして分類したり、バチルス・サチルスの変種として分類する文献もある。Natto bacteria adhere to rice straw and are widely present in nature. Although taxonomically classified as Bacillus subtilis, there is also a literature that classifies as Bacillus natto or classifies as a variant of Bacillus subtilis because it produces a sticky material specific to natto and requires biotin.
納豆菌のL−リジン、L−スレオニン、分岐鎖アミノ酸の生合成調節機構は完全に解明されておらず、更にこれらのアミノ酸の生合成能を向上させる試みも全く行われていないのが現状であった。The biosynthesis regulation mechanism of L-lysine, L-threonine and branched chain amino acids of Bacillus natto has not been completely elucidated, and no attempt has been made to improve the biosynthesis ability of these amino acids. there were.
そこで、本発明者らは、多様な検討を重ねた結果として、人工的に変異処理して得た変異納豆菌をL−リジンのアナログの1つであるS−(β−Aminoethyl)−cysteine(AEC)含有培地で培養して得られた耐性株について、L−リジン分泌能を検討したところ、この耐性株がL−リジンを分泌している新知見を得た。更に、他のL−リジンのアナログである4−AzalysineやOxalysineに対する耐性株も上記した特性を有することも見出した。Accordingly, as a result of various studies, the present inventors obtained a mutant Bacillus natto obtained by artificial mutation treatment as S- (β-Aminoethyl) -cysteine (an analog of L-lysine). When the L-lysine secreting ability of the resistant strain obtained by culturing in the medium containing AEC) was examined, new findings were obtained that this resistant strain secreted L-lysine. Furthermore, it discovered that the resistant strain with respect to 4-Azalysine and Oxalysine which are other analogs of L-lysine also had the above-mentioned characteristic.
また、本発明者らは、様々なテストを行い、人工的に変異処理して得た変異納豆菌からL−スレオニン分解能を欠失させ、次にこの変異株を再び変異処理してL−スレオニンのアナログの1種であるα−Amino−β−hydroxyvaleric acid(AHV)含有培地で培養して得られた耐性株について、L−スレオニン分泌能を検討したところ、この耐性株がL−スレオニンを分泌することを見出した。In addition, the present inventors conducted various tests, deleted L-threonine resolution from mutant Bacillus natto obtained by artificial mutation, and then mutated the mutant again to give L-threonine. Of a resistant strain obtained by culturing in a medium containing α-Amino-β-hydroxyvaleric acid (AHV), which is one of the analogs of L-threonine, the L-threonine secreting ability was examined. I found out.
更に、本発明者らは、各種の検討を行い、人工的に変異処理して得た変異納豆菌を分岐鎖アミノ酸のアナログの1つであるβ−Hydroxyleucin(HL)含有培地で培養して得られた耐性株について、分岐鎖アミノ酸分泌能を検討したところ、L−バリン、L−ロイシン、L−イソロイシンを単独又は同時に分泌することを見出した。更に、分岐鎖アミノ酸の他のアナログであるα−Aminobutyric acidやNorvalineに対する耐性株も同様な特性を有することを見出した。Furthermore, the present inventors have conducted various studies and obtained by culturing mutant Bacillus natto obtained by artificial mutation treatment in a medium containing β-hydroxyleucin (HL), which is one of the branched chain amino acid analogs. The obtained resistant strain was examined for the ability to secrete branched chain amino acids, and it was found that L-valine, L-leucine and L-isoleucine were secreted alone or simultaneously. Furthermore, it discovered that the resistant strain with respect to (alpha) -Aminobutyric acid and Norvaline which are other analogs of branched chain amino acid has the same characteristic.
すなわち本発明者らは、選択培地としてL−リジン、L−スレオニン、分岐鎖アミノ酸などのアナログ含有培地を使用してこれらのアミノ酸高分泌性の納豆菌の育種に成功し、次にこのような育種納豆菌を使用して通常の納豆製造法により納豆を製造することにより、L−リジン、L−スレオニン、または/および分岐鎖アミノ酸を多く含む納豆の製造が可能であることを確認して本発明を完成するに至った。That is, the present inventors succeeded in breeding these amino acid highly secreting natto using a medium containing an analog such as L-lysine, L-threonine, and branched chain amino acid as a selective medium. By confirming that it is possible to produce natto containing a large amount of L-lysine, L-threonine, and / or branched chain amino acids by producing natto using a conventional natto production method using breeding natto bacteria The invention has been completed.
本発明で使用する納豆菌の親株としては、自然界からの分離株、工業的に使用されている菌株、或いは栄養要求性や薬剤耐性を付与した菌株などを用いることが出来る。As the parent strain of Bacillus natto used in the present invention, an isolated strain from the natural world, an industrially used strain, a strain imparted with auxotrophy or drug resistance, and the like can be used.
本発明で用いられる納豆菌の変異方法はいかなる変異方法でもよい。即ち、自然突然変異、紫外線照射やエックス線照射などの物理的変異、エチルメチルスルホン酸やN−メチル−N−ニトロ−N−ニトロソグアニジン(NTG)などの化学的変異を用いることができる。Any mutation method may be used as a method for mutation of Bacillus natto used in the present invention. That is, natural mutation, physical mutation such as ultraviolet irradiation or X-ray irradiation, and chemical mutation such as ethylmethylsulfonic acid or N-methyl-N-nitro-N-nitrosoguanidine (NTG) can be used.
本発明では、目的とする育種納豆菌の選択培地に特徴を有するものである。L−リジンを分泌する納豆菌を取得するには、選択培地にL−リジンのアナログを添加することが望ましい。L−リジンのアナログとしては、AEC、4−Azalysine,Oxalysineなどを用いることができる。L−リジンのアナログの添加濃度は変異操作を行う納豆菌のアナログ耐性度を調べて実施する必要があるが、50〜5000μg/ml程度の濃度で選択培地に添加するとよい。In this invention, it has the characteristics in the selective culture medium of the target breeding natto. In order to obtain Bacillus natto secreting L-lysine, it is desirable to add an analog of L-lysine to the selective medium. As an analog of L-lysine, AEC, 4-Azalysine, Oxalosine, etc. can be used. The concentration of the L-lysine analog added should be determined by examining the degree of analog resistance of Bacillus natto performing the mutation operation, but it may be added to the selective medium at a concentration of about 50 to 5000 μg / ml.
また、L−スレオニンを分泌する納豆菌を取得するには、選択培地にL−スレオニンのアナログを添加することが望ましい。L−スレオニンの分解能を有する納豆菌のときは、予めL−スレオニン分解能を変異により欠失するとよい。L−スレオニンのアナログとしては、AHVなどを用いることができる。L−スレオニンのアナログの添加濃度は、使用する納豆菌のアナログ耐性度を検討して決める必要があるが、100〜8000μg/ml程度の濃度で選択培地に添加するとよい。In order to obtain Bacillus natto secreting L-threonine, it is desirable to add an analog of L-threonine to the selective medium. In the case of Bacillus natto having the resolution of L-threonine, the L-threonine resolution may be deleted in advance by mutation. As an analog of L-threonine, AHV or the like can be used. The concentration of the L-threonine analog should be determined by examining the degree of analog resistance of the natto bacteria to be used, but it may be added to the selective medium at a concentration of about 100 to 8000 μg / ml.
更に、分岐鎖アミノ酸を分泌する納豆菌を取得するには、選択培地に分岐鎖アミノ酸のアナログを添加することが望ましい。分岐鎖アミノ酸のアナログとしては、HL、α−Aminobutylic acid、Norvalineなどを用いることができる。分岐鎖アミノ酸のアナログの添加濃度は、変異操作を行う納豆菌の耐性度にもよるが、100〜8000μg/ml程度の濃度で選択培地に添加するとよい。Furthermore, in order to obtain Bacillus natto secreting branched chain amino acids, it is desirable to add an analog of the branched chain amino acid to the selective medium. As an analog of a branched chain amino acid, HL, α-Aminobutyric acid, Norvaline, or the like can be used. The addition concentration of the branched chain amino acid analog may be added to the selective medium at a concentration of about 100 to 8000 μg / ml, although it depends on the resistance of Bacillus natto performing the mutation operation.
改良をしたい納豆菌を変異処理し、次にAEC、AHVまたはHLなどのアナログを添加した固体の選択培地に播菌し、37℃、5日間培養し、形成したコロニーを純化する。この純化した納豆菌を使用して納豆をつくり、L−リジン、L−スレオニンまたは分岐鎖アミノ酸を多く含有するようになった納豆菌が取得選択できる。The Bacillus natto to be improved is mutated and then inoculated on a solid selective medium supplemented with an analog such as AEC, AHV or HL and cultured at 37 ° C. for 5 days to purify the formed colonies. Natto is made using this purified Bacillus natto, and Bacillus natto containing a large amount of L-lysine, L-threonine or branched chain amino acids can be obtained and selected.
以上のように納豆菌を育種開発したL−リジン、L−スレオニンまたは分岐鎖アミノ酸の高分泌株を使用して実際の納豆生産に利用するには、従来よりの納豆製造設備の使用がそのまま可能であり、新たな設備投資の必要はない。このようにして、育種開発した納豆菌を用いることにより、L−リジン、L−スレオニンまたは分岐鎖アミノ酸が高濃度で含有された栄養豊富な新規納豆の生産が可能である。In order to use L-lysine, L-threonine, or a highly secreted branched-chain amino acid strain that has been developed for breeding natto as described above, actual natto production equipment can be used as it is. There is no need for new capital investment. In this way, by using a natto bacterium that has been bred and developed, it is possible to produce a nutritious new natto containing a high concentration of L-lysine, L-threonine or branched chain amino acid.
本特許の記載技術を用いれば、大豆や各種穀物類を原料として、バチルス属各種微生物の同様な育種株を使用することにより、L−リジン、L−スレオニンまたは分岐鎖アミノ酸の含有量が向上した発酵食品、飼料などの製造が可能であり、本特許の範囲に含まれる。Using the technology described in this patent, the content of L-lysine, L-threonine or branched chain amino acids was improved by using similar breeding strains of various microorganisms of the genus Bacillus, using soybeans and various cereals as raw materials. Fermented foods, feeds, etc. can be produced and are within the scope of this patent.
以下に本発明の実施例について記述する。Examples of the present invention will be described below.
本実施例において使用した培地は、LB培地、改変Spizizen最小培地である。The medium used in this example is an LB medium or a modified Spizzen minimal medium.
LB培地組成は、トリプトン10g、酵母エキス5g、食塩5g、水1L、pH6.8である。固体培地には寒天2%を添加した。The composition of the LB medium is tryptone 10 g, yeast extract 5 g, salt 5 g, water 1 L, pH 6.8. Agar 2% was added to the solid medium.
改変Spizizen最小培地組成は、グルコース5g、クエン酸Na1g、硫安2g、燐酸1カリウム6g、燐酸2カリウム14g、硫酸マグネシウム7水塩0.2g、ビオチン0.1mg、水1L、pH6.8である。固体培地には寒天2%を添加した。The modified Spizzen minimal medium composition is 5 g glucose, 1 g Na citrate, 2 g ammonium sulfate, 6
市販納豆から分離した納豆菌NA−1株をLB培地で1晩培養し、滅菌生理食塩水で洗浄後、同生理食塩水中で通常の方法によりNTG変異処理を行った。NTG変異処理後の洗浄菌液をAEC1000μg/ml含有の改変Spizizen最小培地に播いた。37℃で1週間培養し、出現したコロニーをLB培地で純化し、次にAEC1000μg/ml含有の改変Spizizen最小培地にてアナログ耐性を確認した。The Bacillus natto NA-1 strain isolated from commercial natto was cultured overnight in LB medium, washed with sterile physiological saline, and then subjected to NTG mutation treatment in the same physiological saline by a conventional method. The washed bacterial solution after the NTG mutation treatment was seeded on a modified Spizzen minimal medium containing 1000 μg / ml of AEC. After culturing at 37 ° C. for 1 week, the appearing colonies were purified with LB medium, and then analog resistance was confirmed with a modified Spizizen minimal medium containing 1000 μg / ml of AEC.
アナログ耐性を確認したAEC耐性株であるNo.1株およびその親株NA−1株を用いて、納豆を作製した。大豆を浸漬後、水切りし、次に蒸煮した。蒸煮大豆1gあたり3000個の胞子を各々植菌し、45gずつPSPトレーに入れ、蓋をして発酵に入れ、40℃、高湿度下で醗酵を行った。No. which is an AEC resistant strain with confirmed analog resistance. Natto was prepared using 1 strain and its parent NA-1 strain. After soaking the soybeans, it was drained and then steamed. 3000 spores per 1 g of steamed soybeans were inoculated, 45 g each were placed in a PSP tray, covered and put into fermentation, and fermented at 40 ° C. and high humidity.
作製した2つの納豆について、納豆中の遊離L−リジン含有量を定量した。その結果、親株NA−1株を使用した場合はL−リジン含有量60mg/納豆100g、AEC耐性株No.1株を使用した場合はL−リジン含有量240mg/納豆100gであり、AEC耐性株使用の納豆において、L−リジン含有量の増大が認められた。(図1)About two produced natto, free L-lysine content in natto was quantified. As a result, when parent strain NA-1 was used, L-lysine content 60 mg / natto 100 g, AEC resistant strain No. When one strain was used, the L-lysine content was 240 mg / natto 100 g, and an increase in the L-lysine content was observed in natto using the AEC resistant strain. (Figure 1)
親株NA−1株からL−スレオニン非分解性株を通常の方法で育種し、次にBreeding the non-degradable L-threonine strain from the parental strain NA-1 by the usual method,
に記載した同様な方法により、AHV3000μg/mlに耐性を示す変異株No.2株を取得した。NA−1株及びNo.2株を使用して、上記の方法により納豆を作製した。次に、作製した納豆中のL−スレオニン含有量を定量した結果、親株NA−1株を使用した場合は、L−スレオニン含有量5mg/納豆100gであり、AHV耐性株No.2株を使用した場合は、L−スレオニン含有量210mg/納豆100gであった。In the same manner as described in the above, mutant No. showing resistance to AHV 3000 μg / ml was used. Two shares were acquired. NA-1 strain and No. Two strains were used to produce natto by the above method. Next, as a result of quantifying the L-threonine content in the produced natto, when the parent strain NA-1 strain was used, the L-threonine content was 5 mg / natto 100 g. When two strains were used, the L-threonine content was 210 mg / natto 100 g.
親株NA−1株からFrom parent strain NA-1
に記載した同様な方法により、HL5000μg/mlに耐性を示す変異株No.3株を取得した。NA−1株及びNo.3株を使用して、上記の方法により納豆を作製した。次に、作製した納豆中の分岐鎖アミノ酸含有量を測定した結果、親株NA−1株を使用した場合は、L−バリン35mg/納豆100g、L−ロイシン80mg/納豆100g、L−イソロイシン15mg/納豆100gであった。一方、HL耐性株No.3株を使用した場合は、L−バリン150mg/納豆100g、L−ロイシン145mg/納豆100g、L−イソロイシン80mg/mlであった。In the same manner as described in the above, mutant no. Acquired 3 shares. NA-1 strain and No. Using 3 strains, natto was prepared by the above method. Next, as a result of measuring the branched chain amino acid content in the produced natto, when the parent strain NA-1 was used, L-valine 35 mg / natto 100 g, L-leucine 80 mg / natto 100 g, L-isoleucine 15 mg / It was 100 g of natto. On the other hand, HL resistant strain No. When three strains were used, L-
上記の各実施例で取得した変異株Bacillus sp.No.1株,No.2株及びNo.3株については、各々FERM AP−20135、FERM AP−20136、FERM AP−20137として、産業技術総合研究所に寄託されている。The mutant Bacillus sp. Obtained in each of the above examples. No. 1 strain, no. 2 strains and No. 2 The three strains are deposited with the National Institute of Advanced Industrial Science and Technology as FERM AP-20135, FERM AP-20136, and FERM AP-20137, respectively.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004270549A JP2006055151A (en) | 2004-08-20 | 2004-08-20 | Method for producing natto |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004270549A JP2006055151A (en) | 2004-08-20 | 2004-08-20 | Method for producing natto |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006055151A true JP2006055151A (en) | 2006-03-02 |
Family
ID=36103137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004270549A Pending JP2006055151A (en) | 2004-08-20 | 2004-08-20 | Method for producing natto |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2006055151A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104397196A (en) * | 2014-12-10 | 2015-03-11 | 杭州元佩特生物科技有限公司 | Preparation method of sour soybean milk rich in natto kinase and pyrroloquinoline quinone |
CN104430911A (en) * | 2014-12-10 | 2015-03-25 | 杭州元佩特生物科技有限公司 | Preparation method of black soybean milk rich in pyrroloquinoline quinone and nattokinase |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08275772A (en) * | 1995-04-06 | 1996-10-22 | Fujitsuko Kk | Bacillus natto, fermented soybean and its production |
JP2000287676A (en) * | 1999-04-07 | 2000-10-17 | Mitsukan Group Honsha:Kk | Bacillus natto capable of highly producing vitamin k2, its breeding and fermented soybean |
WO2001093696A1 (en) * | 2000-06-02 | 2001-12-13 | Ikeda Food Research Co., Ltd. | PROCESS FOR PRODUCING FERMENTED FOODS RICH IN η-AMINOBUTYRIC ACID AND FREE AMINO ACIDS |
JP2003289853A (en) * | 2002-04-02 | 2003-10-14 | Asahimatsu Shokuhin Kk | Bacillus natto having high productivity of glutamic acid and natto having high glutamic acid content produced by using the bacterial strain |
-
2004
- 2004-08-20 JP JP2004270549A patent/JP2006055151A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08275772A (en) * | 1995-04-06 | 1996-10-22 | Fujitsuko Kk | Bacillus natto, fermented soybean and its production |
JP2000287676A (en) * | 1999-04-07 | 2000-10-17 | Mitsukan Group Honsha:Kk | Bacillus natto capable of highly producing vitamin k2, its breeding and fermented soybean |
WO2001093696A1 (en) * | 2000-06-02 | 2001-12-13 | Ikeda Food Research Co., Ltd. | PROCESS FOR PRODUCING FERMENTED FOODS RICH IN η-AMINOBUTYRIC ACID AND FREE AMINO ACIDS |
JP2003289853A (en) * | 2002-04-02 | 2003-10-14 | Asahimatsu Shokuhin Kk | Bacillus natto having high productivity of glutamic acid and natto having high glutamic acid content produced by using the bacterial strain |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104397196A (en) * | 2014-12-10 | 2015-03-11 | 杭州元佩特生物科技有限公司 | Preparation method of sour soybean milk rich in natto kinase and pyrroloquinoline quinone |
CN104430911A (en) * | 2014-12-10 | 2015-03-25 | 杭州元佩特生物科技有限公司 | Preparation method of black soybean milk rich in pyrroloquinoline quinone and nattokinase |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5910978B2 (en) | Non-protein amino acid-producing lactic acid bacteria and their uses | |
CN103221531B (en) | Lactobacillus helveticus with high protein hydrolysing activity | |
JP4823318B2 (en) | Process for producing fermented soybeans with increased .GAMMA.-aminobutyric acid content. | |
CN105733983B (en) | Isolated microbial strains lactobacillus gasseri MCC2 DSM 23882 and application thereof | |
CN100455203C (en) | A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survival property, intestinal | |
JP2009542255A (en) | Method for producing L-arginine using Corynebacterium glutamicum | |
KR20070038985A (en) | Selenium-enriched biomass, method for preparing thereof and probiotic and nutraceutical products including said biomass | |
Marklinder et al. | Fermentation properties of intestinal strains of Lactobacillus, of a sour dough and of a yoghurt starter culture in an oat-based nutritive solution | |
JPWO2007097374A1 (en) | Lactic acid bacteria having the ability to produce γ-aminobutyric acid | |
US20230235276A1 (en) | Novel lactococcus lactis subspecies lactis isolate wflu-12 and use thereof | |
JP4313615B2 (en) | Novel lactic acid bacteria having immunostimulatory activity and γ-aminobutyric acid producing ability, and use thereof. | |
JP2000014356A (en) | Production of gaba-containing beverage and food product | |
CN109266572B (en) | Lactobacillus casei mutant strain for producing glutamine transaminase and application thereof | |
Barus et al. | Lactic acid bacteria from tempeh and their ability to acidify soybeans in tempeh fermentation | |
Soković-Bajić et al. | Characterization of pH resistance and the proteolytic activity of GABA producing Lactobacillus brevis BGZLS10-17 in preparation of fermented milk beverage and the effects on the symptoms of the experimental autoimmune encephalomyelitis | |
KR101150148B1 (en) | Novel yeast mutant containing increased glutathione content, method for producing the same and use thereof | |
JP4813902B2 (en) | Anti-stress agent | |
EP3092320A1 (en) | New strains of the genus lactobacillus and use thereof | |
JP2006055151A (en) | Method for producing natto | |
KR101575867B1 (en) | Method for producing a grain composition having high free calcium level | |
KR102439500B1 (en) | Bacillus amyloliquefaciens NY-PSH 124-1 strain and method for producing branched chain amino acid using the same | |
KR101241288B1 (en) | Method for preparing composite microorganism producing glutamic acid and flavoring material | |
Ibrahim et al. | Towards an efficient starter culture to produce dawadawa botso: a traditional condiment produced by fermentation of Hibiscus sabdariffa seeds | |
CN108967269A (en) | Method for improving dissolved oxygen in aquaculture pond by using mixture containing three lactobacillus strains | |
WO2022167135A1 (en) | Plant-based products having increased lysine content fermented with l. paracasei and optionally further bacillus amyloliquefaciens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070731 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070912 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090415 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100608 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101026 |